Overview
Honghao Zhang practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Multiple Myeloma, Leukemia, Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL).
They are actively involved in clinical research, co-authoring 24 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Honghao Zhang
Is Honghao Zhang a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Honghao Zhang is classified as an Experienced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Honghao Zhang participate in research or clinical trials?
Yes. Honghao Zhang has published 24 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Honghao Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Zhang isExperienced. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaZhang isExperienced. Learn about Leukemia.
- Multiple MyelomaZhang isExperienced. Learn about Multiple Myeloma.